Quidel

News Releases

Webcast ImageWebcast
Q3 2017 Quidel Corporation Earnings Conference Call (Live)
11/01/17 at 2:00 p.m. PT
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Date Title
10/17/17Quidel Receives FDA Clearance for Its Solana® RSV + hMPV Assay
10/13/17Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017
10/06/17Quidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care Settings
09/28/17Quidel Announces Early Termination of the Hart-Scott-Rodino Waiting Period for Its Pending Acquisition of Alere’s Triage® B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
09/18/17Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
09/08/17Quidel to Participate in the CEO Series Conference Call Hosted by Canaccord Genuity
07/31/17Quidel to Present at the 37th Annual Canaccord Genuity Growth Conference
07/26/17Quidel Reports Second Quarter 2017 Financial Results
07/17/17Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets
07/14/17Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017
06/28/17Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Respiratory Syncytial Virus (RSV) Assay
06/22/17Quidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®
06/07/17Quidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay
05/30/17Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay
05/24/17Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay
05/16/17Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses
05/11/17Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections
05/01/17Quidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
04/24/17Quidel Reports First Quarter 2017 Financial Results
04/11/17Quidel to Hold First Quarter 2017 Financial Results Conference Call on April 24, 2017
03/02/17Quidel to Present at the Barclays Global Healthcare Conference
02/08/17Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
01/25/17Quidel to Hold Fourth Quarter and Full Year 2016 Financial Results Conference Call on February 8, 2017
01/23/17Quidel Announces Modification of Revenue Reporting Categories
01/06/17Quidel Announces Preliminary Revenue for Fourth Quarter 2016